• No results found

Comment on "a Better Way to Decrease Knee Swelling in Patients with Knee Osteoarthritis: A Single-Blind Randomised Controlled Trial"

N/A
N/A
Protected

Academic year: 2021

Share "Comment on "a Better Way to Decrease Knee Swelling in Patients with Knee Osteoarthritis: A Single-Blind Randomised Controlled Trial""

Copied!
3
0
0

Bezig met laden.... (Bekijk nu de volledige tekst)

Hele tekst

(1)

Letter to the Editor

Comment on “A Better Way to Decrease Knee Swelling in

Patients with Knee Osteoarthritis: A Single-Blind Randomised

Controlled Trial”

Max Broere , Yoshka van der Tuijn , Ingrid A. Szilagyi , and Erin M. Macri

Department of General Practice, Erasmus MC University Medical Center, Rotterdam, Netherlands

Correspondence should be addressed to Ingrid A. Szilagyi; i.szilagyi@erasmusmc.nl and Erin M. Macri; e.macri@erasmusmc.nl Received 4 July 2019; Accepted 21 August 2019; Published 29 September 2019

Academic Editor: Massimiliano Valeriani

Copyright © 2019 Max Broere et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

With great interest, we read the article of Sari et al. [1] about decreasing knee swelling in patients with knee osteoarthritis using intermittent pneumatic compression (IPC). To our knowledge, this is the first study describing the use of IPC as a treatment for knee osteoarthritis. The authors found significant effects on reducing knee swelling. The topic of research is relevant as knee osteoarthritis is the most common chronic joint disorder affecting millions of people worldwide [2]; however, after reading the article, several questions regarding the study remain unanswered to us. We hope the authors can provide us more insight into this study. Firstly, the title, introduction, results, and discussion suggest that the authors’ main focus in this study was knee swelling. In the first statement of the introduction, knee swelling is described as the most common symptom of knee osteoarthritis; however, the literature generally describes that knee OA typically involves knee pain, stiffness, and loss of function. While swelling is not uncommon, we re-spectfully believe this statement may be overstating the clinical importance of swelling in knee OA. To complicate matters, in the sample size calculation (Section 2.5 in the article), knee joint range of motion (ROM) was reported to be the primary outcome measure—this does not match the stated aims of the study. To try and clarify this discrepancy, we looked up the study protocol, which stated that knee swelling and pain intensity were the primary outcome measures. Unfortunately, we also noticed that the trial protocol was registered several years after completion of data collection (the actual study completion date is June 1, 2012)

and just 5 days before the manuscript was submitted for publication. We cannot help but wonder if ROM was in fact once the primary outcome, but this cannot be confirmed given the very late registration of the trial protocol. The purpose of a trial protocol is to ensure research integrity. We would like to recommend avoiding the inappropriate use of the protocol registration system for future research.

Secondly, some details about participant characteristics and dropouts have not been reported in this manuscript. We noticed that all 9 participants who were lost to follow-up were in the cold pack group (CP group). It remains unclear when participants were informed about which group they were allocated to, so could these 9 dropouts in one group be related to a lack of allocation concealment? In addition, was this accounted for in the final analyses? If so, how? We respectfully suggest it would be more appropriate to handle dropouts using an intention-to-treat analysis (ITT). According to the CONSORT guidelines on reporting of RCTs [3], the number of participants in each group should be analyzed using an ITT analysis. Furthermore, although the exclusion criteria are well described, the inclusion cri-teria remain unclear to us. Which definition of the American College of Rheumatology criteria (ACR criteria) [4] did the authors use to include patients? Additionally, the severity of the osteoarthritis and which knee compartments were in-volved would be interesting to know.

Finally, we respectfully question the use of measuring tape to quantify knee joint swelling and the interpretation of these results. Most outcome measures used in this article

Hindawi

Pain Research and Management Volume 2019, Article ID 2619437, 2 pages https://doi.org/10.1155/2019/2619437

(2)

are widely accepted and validated, such as the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC), dynamometer, goniometer, and Visual Ana-logue Scale (VAS). But the validation of the measuring tape remains unclear. We recognize that the authors ac-knowledged that imaging would have been a better option but that this was cost-prohibitive and, admittedly, we cannot offer an alternative, equally affordable clinical measure for quantifying swelling objectively. Can the au-thors comment on this outcome measure’s reliability and have properties such as minimal detectable difference or minimal clinically important difference [5] been estab-lished in this population? Knowing these values would make it easier to interpret the results. We note the authors have relied solely on p values to determine whether treatment was effective. Current best practices encourage authors to report effect sizes and uncertainty metrics in addition to p values [6]. Since the authors found no be-tween-group differences in pain or physical function scores, we question whether reduced knee swelling in these patients translates into clinically meaningful improvement. Overall, we encourage the authors to exercise caution in interpreting the results of this study so as not to overstate the results of their work.

In conclusion, we would like to thank the authors for their work. We appreciate the substantial undertaking of conducting a randomized controlled trial and commend the authors for seeking novel treatments to address this im-portant clinical population. We hope our feedback and subsequent author response will serve to improve the reader’s interpretation of the current study findings and similar research in the future.

Conflicts of Interest

The authors declare that they have no conflicts of interest.

Authors’ Contributions

Max Broere and Yoshka van der Tuijn contributed equally to this work.

References

[1] Z. Sari, O. Aydo˘gdu, I. Demirb¨uken, S. U. Yurdalan, and M. G. Polat, “A better way to decrease knee swelling in patients with knee osteoarthritis: a single-blind randomised controlled trial,” Pain Research and Management, vol. 2019, Article ID 8514808, 7 pages, 2019.

[2] J. Runhaar, M. van Middelkoop, M. Reijman et al., “Prevention of knee osteoarthritis in overweight females: the first preventive randomized controlled trial in osteoarthritis,” The American Journal of Medicine, vol. 128, no. 8, pp. 888–895, 2015. [3] D. Moher, K. F. Schulz, D. G. Altman, and G. Consort, The

CONSORT Statement: Revised Recommendations for Improving the Quality of Reports of Parallel-Group Randomised Trials, Elsevier, Amsterdam, Netherlands, 2001.

[4] R. Altman, E. Asch, D. Bloch et al., “Development of criteria for the classification and reporting of osteoarthritis: classification of osteoarthritis of the knee,” Arthritis & Rheumatism, vol. 29, no. 8, pp. 1039–1049, 1986.

[5] F. Angst, T. Benz, S. Lehmann, A. Aeschlimann, and J. Angst, “Multidimensional minimal clinically important differences in knee osteoarthritis after comprehensive rehabilitation: a pro-spective evaluation from the Bad Zurzach Osteoarthritis Study,” RMD Open, vol. 4, no. 2, article e000685, 2018. [6] D. Chavalarias, J. D. Wallach, A. H. Li, and J. P. Ioannidis,

“Evolution of reporting P values in the biomedical literature, 1990–2015,” Journal of the American Medical Association, vol. 315, no. 11, pp. 1141–1148, 2016.

(3)

Stem Cells

International

Hindawi www.hindawi.com Volume 2018 Hindawi www.hindawi.com Volume 2018

MEDIATORS

INFLAMMATIONof

Endocrinology

International Journal of

Hindawi www.hindawi.com Volume 2018 Hindawi www.hindawi.com Volume 2018

Disease Markers

Hindawi www.hindawi.com Volume 2018 BioMed Research International

Oncology

Journal of Hindawi www.hindawi.com Volume 2013 Hindawi www.hindawi.com Volume 2018

Oxidative Medicine and Cellular Longevity

Hindawi

www.hindawi.com Volume 2018

PPAR Research

Hindawi Publishing Corporation

http://www.hindawi.com Volume 2013 Hindawi www.hindawi.com

The Scientific

World Journal

Volume 2018 Immunology Research Hindawi www.hindawi.com Volume 2018 Journal of

Obesity

Journal of Hindawi www.hindawi.com Volume 2018 Hindawi www.hindawi.com Volume 2018 Computational and Mathematical Methods in Medicine Hindawi www.hindawi.com Volume 2018

Behavioural

Neurology

Ophthalmology

Journal of Hindawi www.hindawi.com Volume 2018

Diabetes Research

Journal of

Hindawi

www.hindawi.com Volume 2018

Hindawi

www.hindawi.com Volume 2018

Research and Treatment

AIDS

Hindawi

www.hindawi.com Volume 2018

Gastroenterology Research and Practice

Hindawi www.hindawi.com Volume 2018

Parkinson’s

Disease

Evidence-Based Complementary and Alternative Medicine Volume 2018 Hindawi www.hindawi.com

Submit your manuscripts at

Referenties

GERELATEERDE DOCUMENTEN

In Section 2, a framework to investigate such an economy is introduced, a stochastic version of the model is developed and the resulting time series behavior of

In order to select relevant studies the following inclusion criteria were applied in the selection process: 1) The title should contain at least one of the following words, or

Het komt nog maar al te vaak voor dat deze metrostations niet heel erg goed te zien zijn, waardoor het reizen door de stad er niet eenvoudiger op wordt.. Daar komt nog bij

De oplossing en zeer veel andere werkbladen om gratis te

Although at first sight the myth might seem like an idealistic glorification of Lesbia, I believe Catullus indeed uses the myth to point to the reality of his relationship

Furthermore, it has surfaced that in some systems induction of newly- appointed principals starts during the recruitment and selection activities, when the

in terms of a structural dualism, have not been encouraged to study issues such as the processes and means by which social hierarchy, diet and body might be drawn together in India,

 Er is goedkopere tegellijm ingekocht, maar deze is van mindere kwaliteit, dus is er meer tegellijm gebruikt.  Er is goedkopere